InvestorsHub Logo
Followers 42
Posts 1152
Boards Moderated 0
Alias Born 03/24/2021

Re: docsetc post# 125156

Wednesday, 08/25/2021 1:47:04 PM

Wednesday, August 25, 2021 1:47:04 PM

Post# of 199091
It's buried in the financials on page 22:

https://backend.otcmarkets.com/otcapi/company/financial-report/297979/content

On July 15, 2021, an action was commenced against Dimitri Savov, a resident of Sofia, Bulgaria, in the Court of Chancery of the State of Delaware seeking a temporary restraining order, injunctive relief, a declaratory judgment and damages arising from illegitimate and false claims made by Mr. Savov regarding his purported ownership of stock in the Company. Additionally, Mr. Savov has made numerous defamatory statements about the Company and its Directors. These actions by Mr. Savov damaged the Company and constitute tortious interference with the Company’s current and prospective business relationships. The Company intends to pursue all available claims and remedies against Mr. Savov to the fullest extent permitted under the law and is in the process of filing a criminal complaint against Mr. Savov in Bulgaria. As 49% owner of IMMB BG, Enzolytics has assisted with the filing of forgery and fraud charges against Mr. Savov in Sofia earlier in the second quarter as well. The Company is working to mitigate the damages caused by Mr. Savov to relationships recently announced between the Company and other entities.



Apparently the lawsuit was filed July 15. The Lonza PR dropped July 21 and some folks (me now included) are wondering if the lawsuit is why it was rescinded. The PR is worded that the two companies "have signed an agreement" and Lonza came back saying the PR had "inaccuracies" so it's all quite a mystery for now. :P

https://seekingalpha.com/news/3717315-enzolytics-and-lonza-bioscience-ink-collaboration-agreement?utm_source=advfn.com&utm_medium=referral

Enzolytics (OTCPK:ENZC) and Lonza Bioscience have signed an agreement to fast-track development and production of anti-HIV and anti-SARS-CoV-2 Monoclonal Antibodies.



The sequence of events:
July 15 - Lawsuit Filed
July 21 - Lonza PR
July 22ish? - Lonza PR removed
August 23 - Quarterly report mentioning the lawsuit and "damages caused by Mr. Savov to relationships recently announced between the Company and other entities."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENZC News